Shanghai Institute Of Biological Products

This study tests a new vaccine called MVA-SIBP to see if it is safe and helps the body fight mpox (monkeypox). About 180 people in the Democratic Republic of the Congo will take part, including adults, teenagers, and children. Half will get the vaccine and half a placebo, and res…

This study tests a new injection called SIBP-A16 to see if it is safe and how the body processes it in premature and full-term infants under 1 year old. The goal is to find the right dose to help prevent RSV, a common and serious lung infection. About 36 infants will take part in…

This study tests a new flu vaccine in 1200 adults aged 60 and older. Participants will receive either the new vaccine or a standard flu shot. Researchers will check how well the vaccine boosts immunity and monitor for any side effects over 30 days.